Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Notes Payables (2020 - 2025)

Bio Essence has reported Notes Payables over the past 6 years, most recently at $1531.0 for Q4 2025.

  • Quarterly results put Notes Payables at $1531.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1531.0 (changed N/A YoY), and the annual figure for FY2025 was $1531.0, changed.
  • Notes Payables for Q4 2025 was $1531.0 at Bio Essence, down from $6966.0 in the prior quarter.
  • Over the last five years, Notes Payables for BIOE hit a ceiling of $70860.0 in Q1 2023 and a floor of $1531.0 in Q4 2025.
  • Median Notes Payables over the past 5 years was $19032.0 (2021), compared with a mean of $22537.6.
  • Biggest five-year swings in Notes Payables: surged 158.61% in 2023 and later crashed 96.43% in 2024.
  • Bio Essence's Notes Payables stood at $19032.0 in 2021, then increased by 14.62% to $21815.0 in 2022, then tumbled by 56.75% to $9436.0 in 2023, then tumbled by 73.17% to $2532.0 in 2024, then crashed by 39.53% to $1531.0 in 2025.
  • The last three reported values for Notes Payables were $1531.0 (Q4 2025), $6966.0 (Q2 2025), and $2414.0 (Q1 2025) per Business Quant data.